Cannabis in cancer care

@article{Abrams2015CannabisIC,
  title={Cannabis in cancer care},
  author={DI Abrams and Manuel Guzm{\'a}n},
  journal={Clinical Pharmacology \& Therapeutics},
  year={2015},
  volume={97}
}
  • DI AbramsM. Guzmán
  • Published 1 June 2015
  • Medicine, Biology
  • Clinical Pharmacology & Therapeutics
Cannabis has been used in medicine for thousands of years prior to achieving its current illicit substance status. Cannabinoids, the active components of Cannabis sativa, mimic the effects of the endogenous cannabinoids (endocannabinoids), activating specific cannabinoid receptors, particularly CB1 found predominantly in the central nervous system and CB2 found predominantly in cells involved with immune function. Delta‐9‐tetrahydrocannabinol, the main bioactive cannabinoid in the plant, has… 

Integrating cannabis into clinical cancer care.

  • D. Abrams
  • Medicine, Biology
    Current oncology
  • 2016
An increasing body of in vitro and animal-model studies supports a possible direct anticancer effect of cannabinoids by way of a number of different mechanisms involving apoptosis, angiogenesis, and inhibition of metastasis.

Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care

Oncologists should familiarize themselves with the available database to be able to better advise their patients on the potential uses of this complementary botanical therapy, and to evaluate whether the preclinical antitumor effects translate into benefit for cancer patients.

Cannabinoids and Pain: New Insights From Old Molecules

The evidence from current research supports the use of medical cannabis in the treatment of chronic pain in adults and calls for larger well-designed studies to determine the long-term efficacy and long- term safety of cannabis/cannabinoids.

Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?

The favorable outcomes demonstrating the benefits of cannabis as an adjunctive treatment to conventional medicines for chemotherapy-induced nausea, vomiting, and cancer-related pain (primarily refractory chronic or neuropathic pain) are described.

The current state and potential direction of cannabis research

The underlying conditions that are significantly controlled or modulated by cannabis are discussed to provide the medical community with a broad synopsis of recent research trials on Cannabis sativa that have indicated its medicinal benefits.

Cannabinoids and cancer pain: A new hope or a false dawn?

Opportunities for cannabis in supportive care in cancer

There is a reasonable amount of evidence to consider cannabis for nausea and vomiting, loss of appetite, and pain as a supplement to first-line treatments, and promising evidence to treat chemotherapy-induced peripheral neuropathy, gastrointestinal distress, and sleep disorders, but the literature is thus far too limited to recommend cannabis for these symptoms.

Should Oncologists Recommend Cannabis?

  • D. Abrams
  • Medicine, Biology
    Current Treatment Options in Oncology
  • 2019
Oncologists and palliative care providers should recommend this botanical remedy to their patients to gain first-hand evidence of its therapeutic potential despite the paucity of results from randomized placebo-controlled clinical trials.

Use of Cannabis and Cannabinoids in Patients With Cancer

Current evidence for use of medical cannabis and cannabinoids in cancer patients is weak, however, healthcare professionals are in an ideal role to monitor and educate patients using medical Cannabis and cannabinoids.
...

References

SHOWING 1-10 OF 75 REFERENCES

Established and potential therapeutic applications of cannabinoids in oncology

The use of cannabinoids should be continued in the areas indicated, and further studies are needed to evaluate other potential uses in clinical oncology.

The Pharmacologic and Clinical Effects of Medical Cannabis

The pharmacology of cannabis, effects of various dosage formulations, therapeutics benefits and risks of cannabis for pain and muscle spasm, and safety concerns of medical cannabis use are described.

The analgesic potential of cannabinoids.

An overview of the history of cannabis use in medicine, cannabinoid signaling pathways, and current data from preclinical as well as clinical studies on using cannabinoids as potential analgesic agents is provided.

Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis‐Based Medicine

No tolerance to the benefit of Sativex on pain or sleep, nor need for dosage increases have been noted in safety extension studies of up to four years, wherein 40–50% of subjects attained good or very good sleep quality, a key source of disability in chronic pain syndromes that may contribute to patients' quality of life.

Cannabinoids and cancer: pros and cons of an antitumour strategy

This article will review the principal molecular pathways modulated by cannabinoids on cancer and summarize pros and cons evidence on the possible future use of endocannabinoid‐based drugs in cancer therapy.

Synergistic interactions between cannabinoid and opioid analgesics.

Cannabinoids in medicine: A review of their therapeutic potential.

Cannabinoids present an interesting therapeutic potential as antiemetics, appetite stimulants in debilitating diseases, analgesics, and in the treatment of multiple sclerosis, spinal cord injuries, Tourette's syndrome, epilepsy and glaucoma.

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

  • R. Pertwee
  • Biology, Medicine
    British journal of pharmacology
  • 2009
Five strategies that have the potential to meet either the efficacy and/or the benefit‐to‐risk ratio of a cannabinoid receptor agonist are focused on.

Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel.

Coadministration of medicinal cannabis, as herbal tea, in cancer patients treated with irinotecan or docetaxel does not significantly influence the plasma pharmacokinetic parameters with and without concomitant medicinal cannabis.

Cannabinoids: potential anticancer agents

Cannabinoids — the active components of Cannabis sativa and their derivatives — exert palliative effects in cancer patients by preventing nausea, vomiting and pain and by stimulating appetite. In
...